About MAYD
MAYD is a Healthcare company based in Berlin (Germany) founded in 2018 by Lukas Mushroom and Hanno Heintzenberg. Non-prescription medicines are ordered and delivered online. MAYD has raised $48.88 million across 2 funding rounds from investors including Lightspeed Venture Partners, Target Global and 468 Capital. Its website getmayd.com draws about 12 thousand monthly visits. MAYD offers products and services including MAYD App. Its focus areas include HealthTech, Healthcare Booking Platforms, Pharmacies and Drugs. Its legal entity is MAYD Group GmbH. Its competitors include medpex, Axiogenesis and Medizinfuchs.
Company details
MAYD was established in 2018 in Berlin, Germany, within the health technology sector. An online platform is provided for users to select and order non-prescription pharmacy products, with delivery services arranged accordingly. Medicine-related queries are addressed, and consultations with pharmacists are facilitated through the platform. Operations center on streamlining access to essential pharmaceutical items for consumers in the region.
- Headquarters Berlin, Germany
- Founders Lukas Mushroom, Hanno Heintzenberg
- SectorsHealthcare
- Email••••••••
- Website getmayd.com
- Social LinkedIn X
- Legal Name Mayd Group Gmbh
- Total Equity Funding$48.88M (USD)
in 2 rounds
- Latest Funding Round$33.85M (USD), Series A
Jan 2022
- InvestorsLightspeed Venture Partners
& 5 more
Products & Services of MAYD
MAYD offers a comprehensive portfolio of products and services, including MAYD App.
App for on-demand medication delivery in 30 minutes
Funding Insights of MAYD
MAYD has successfully raised a total of $48.88M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $33.85 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $48.88M
- Total Rounds 2
- Last Round Series A — $33.85M
- First Round $15.04M
(Oct 2021)
- Investors Count 6
All 2 funding rounds of MAYD with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2022 | $33.85M | Series A | – | Lightspeed Venture Partners | |
| Oct 2021 | $15.04M | Seed | – | – |
6 investors in total: 4 institutional and 2 angel.
Investors in MAYD
MAYD has secured backing from 6 investors, including venture fund and angel investors. Prominent investors backing the company include Lightspeed Venture Partners, Target Global and 468 Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investing in innovative companies across global sectors is undertaken by Lightspeed Venture Partners. | 1997 | lsvp.com | Menlo Park, United States | |
Venture capital firm | targetglobal.vc | London, United Kingdom | ||
Venture capital funding is provided to early-stage startups from Berlin. | 468cap.com | Berlin, Germany | ||
Earlybird is recognized as a venture capital investor focused on early-stage tech companies. | earlybird.com | Berlin, Germany | ||
JE Jochen Engert | Co-founder of FlixBus, active angel investor in mobility and tech startups. | unknown_0edb3e7a7c894529b | ||
LS Lea Sophie Cramer | Co-founder of Amorelie, angel investor in Indian startups, focus on consumer tech. | unknown_23798e05ecdf45118 |
Investor details for MAYD
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MAYD
2 people are tracked at MAYD (2 in leadership).
| Name | Role | Group |
|---|---|---|
Lukas Mushroom | Co-Founder & Managing Director | Leadership |
Hanno Heintzenberg | Co-Founder & Managing Director | Leadership |
Complete people profiles for MAYD
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MAYD
3 dated milestones of MAYD across 4 years, from founding to its latest funding, stage changes and deals.
- Founded MAYD is founded.
- Funding First funding round of $15.0M.
- Funding Latest funding round, Series A, of $33.8M.
Competitors of MAYD
MAYD has 3 listed competitors in our database. They include medpex, Axiogenesis and Medizinfuchs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medpex.de | 2005 | Ludwigshafen, Germany | Medicines for health conditions are sold online by medpex. | |||
| axiogenesis.com | 2000 | Cologne, Germany | Generic medicines are sold via an online pharmacy platform. | |||
| medizinfuchs.de | 2009 | Berlin, Germany | Operates a marketplace for pharmacy products to facilitate online purchasing. |
Detailed competitors of MAYD
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MAYD
The website of MAYD (getmayd.com) receives about 12K visits a month.
- Monthly visits12K
▲ 40.5% vs previous month
Websites whose visitors overlap most with MAYD. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
forum-apotheke-stuttgart.de | forum-apotheke-stuttgart.de | 100% | #9,400,009 | – | |
europa-shop-apotheke.de | europa-shop-apotheke.de | 89% | #2,568,140 | – | |
apotree.de | apotree.de | 87% | #5,310,090 | – | |
dieapotheke.com | dieapotheke.com | 83% | #5,060,729 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MAYD
MAYD was founded in 2018 and raised its 1st funding round 3 years after it was founded.
MAYD is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
MAYD is a funded company, having raised a total of $48.88M across 2 funding rounds to date. The company's 1st funding round was a Seed of $15.04M, raised on Oct 2021.
MAYD was established in 2018 in Berlin, Germany, within the health technology sector. An online platform is provided for users to select and order non-prescription pharmacy products, with delivery services arranged accordingly. Medicine-related queries are addressed, and consultations with pharmacists are facilitated through the platform. Operations center on streamlining access to essential pharmaceutical items for consumers in the region.
MAYD's top competitors include medpex, Axiogenesis and Medizinfuchs.
MAYD offers MAYD App.
MAYD has 6 investors. Key investors include Lightspeed Venture Partners, Target Global, 468 Capital, Earlybird, and Jochen Engert.
MAYD operates through Mayd Group Gmbh.